November 19, 2013

Devicare is awarded the 1st Prize of the 2013 XXI BioEntrepreneurship co-organized by La Caixa, Barcelona Activa and Biocat.


The award, which recognizes the biotechnology company of the year with most growth potential in Catalonia is endowed with 10,000 euros, accounting services and tax advisory from Vilar Riba group, acceleration courses at the University of Cambridge and EADA Business School , participation in an International Fair in the sector, six free months in the incubator of Barcelona Activa, a year of access to the technology offered at Barcelona Science Park with the status of associate and a press report in a reference case .

The other two finalists were Aniling, spin-off of the Institute of Predictive and Personalized Medicine of Cancer (IMPPC) which designs and develops technologies to improve DNA sequencing techniques and Cebiotex, spin-off of the Hospital Sant Joan de Deu and UPC which has developed a technology platform based on nanofiber membrane (biocompatible and biodegradable) that release drugs and are used in local treatment after surgery for tumor removal.

More information:

– Article in Biocat

– Article in “El Mundo” Catalonia edition: Innovative Supplement